InnoStar boasts nearly 60,000 square meters of modern facilities and a research team of more than 1,000 employees, located in Shanghai, Nantong, Shenzhen, Huangshan and etc. InnoStar has the industry-leading international service capability and is in line with international standards. It has successively passed GLP inspections by various regulatory authorities including US FDA and received the NMPA GLP certification, OECD GLP certification (Netherlands), AAALAC certification, and CAP certification, etc. It provides global pharmaceutical enterprises and research institutions with comprehensive one-stop new drug research and development services that meet domestic and international registration standards. The business covers early druggability assessment, nonclinical pharmacodynamics, nonclinical pharmacokinetics, nonclinical safety evaluation, clinical biological sample analysis and biomarkers and translational research, etc.